Article
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
Journal of medical virology - 1 Mar 2020
Uchida Yoshihito, Nakao Masamitsu, Tsuji Shohei, Uemura Hayato, Kouyama Jun-Ichi, Naiki Kayoko, Motoya Daisuke, Sugawara Kayoko, Nakayama Nobuaki, Imai Yukinori, Tomiya Tomoaki, Mochida Satoshi
Abstract excerpt
The significance of switching of the nucleos(t)ide analog used to treat patients with hepatitis B virus (HBV) from entecavir (ETV) to tenofovir alafenamide fumarate (TAF) is uncertain. The subjects of this study were 159 patients with HBV who received treatment with ETV followed by TAF. Among these patients, serial changes in the HBV marker levels were monitored in 92 patients in whom the serum HBsAg levels were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.